Laddar...
Targeting the cancer kinome through polypharmacology
Kinase inhibitors are the largest class of new cancer drugs. However, it is already apparent that most tumours can escape from the inhibition of any single kinase. If it is necessary to inhibit multiple kinases, how do we choose which ones? In this Opinion article, we discuss some of the strategies...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2880454/ https://ncbi.nlm.nih.gov/pubmed/20094047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc2787 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|